Life sciences · Journal article
Frontiers in Public Health · October 29, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Objective Using Fujian’s multi-source Coronavirus Disease 2019 (COVID-19) surveillance system, this study compared epidemiological features and indicator associations of two successive epidemic waves to optimize epidemic surveillance and prevention strategies. Methods Multi-source surveillance data were collected from week 49 of 2022 (the week of December 7, 2022, when the 10 optimization measures were issued) to week 29 of 2023 (July 17–23, 2023) in Fujian Province, including reported COVID-19 cases, fever clinic visits, population nucleic acid testing, sentinel hospital surveillance, hospitalized severe cases, and viral variants. Descriptive epidemiology, Spearman correlation, and lagged cross-correlation analyses were adopted for data evaluation. Results The first wave showed a sharp peak pattern, with most indicators peaking around weeks 51–52/2022 and reported cases peaking at week 1/2023; the second wave exhibited a gradual peak at week 21/2023. Peak levels of the second wave were 10.7–99.9% lower across indicators, although the markedly reduced nucleic acid testing volume and changed surveillance conditions warrant cautious interpretation of cross-wave comparisons. The interval between the two epidemic peaks was about 5 months, and severe cases consistently lagged infection peaks by approximately 2 weeks. Indicators were strongly correlated, with the highest correlation between sentinel and nucleic acid positivity rates (rs = 0.92, p < 0.001); lagged cross-correlation analysis indicated that these two indicators moved essentially in synchrony. The XBB variant took approximately 4 weeks from initial local detection to predominance alongside the second epidemic peak. Conclusion The two observed epidemic peaks were approximately 5 months apart, and multi-source surveillance indicators showed high temporal concordance. However, lagged cross-correlation indicated that the indicators moved essentially in synchrony, so sentinel surveillance should be regarded as a complementary monitoring tool rather than a proven early-warning measure. The XBB variant reached predominance approximately 4 weeks after initial local detection in this episode, a descriptive observation that cannot be generalized as a validated predictive tool. These findings facilitate multi-wave epidemic preparedness and surveillance improvement.